Susan Bobulsky
Chief Commercial Officer, MRD at Adaptive Biotechnologies. Based in Seattle, Washington.
- Rank
- 8231st of 14,644
- Companies held
- 1
- Largest holding
- ADPT, 100.0% of total
- Latest SEC filing
- Nov 11, 2026
What the $10.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Adaptive Biotechnologies ADPT Common Stock | Directly | 387,475 | $28.05 | $10.9M | 100.0% | Form 4, Nov 11, 2026 |
Share counts are the amounts Susan Bobulsky reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Sold | ADPT | 1,875 | $32.00 | $60K | View |
| Oct 6, 2026 | Sold | ADPT | 6,444 | $30.00 | $193K | View |
| Sep 15, 2026 | Sold | ADPT | 1,195 | $27.00 | $32K | View |
| Aug 10, 2026 | Sold | ADPT | 3,000 | $25.00 | $75K | View |
| Jul 30, 2026 | Sold | ADPT | 1,299 | $24.00 | $31K | View |
| Jul 16, 2026 | Sold | ADPT | 5,000 | $23.00 | $115K | View |
| Jul 1, 2026 | Sold | ADPT | 487 | $22.00 | $11K | View |
| Jun 25, 2026 | Sold | ADPT | 5,000 | $20.50 | $103K | View |
| Jun 11, 2026 | Sold | ADPT | 5,000 | $19.00 | $95K | View |
| Jun 4, 2026 | Sold | ADPT | 11,000 | $18.00 | $198K | View |
| Mar 11, 2026 | Sold | ADPT | 41,338 | $13.17 | $544K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8228 | Chen Seng Heng Director, Sea | $10.9M |
| 8229 | Becky Schmitt EVP and Chief People Officer, PepsiCo. Purchase, NY | $10.9M |
| 8230 | Christos Dimopoulos EVP and CSO, Bunge Global SA. Chesterfield, MO | $10.9M |
| 8231 | Susan Bobulsky Chief Commercial Officer, MRD, Adaptive Biotechnologies. Seattle, WA | $10.9M |
| 8232 | Gary K. Schick SVP, CHRO, Jabil. St. Petersburg, FL | $10.9M |
| 8233 | Nandakumar Cheruvatath See Remarks below, Eaton Corporation. Hollywood, FL | $10.9M |
| 8234 | Kevin Andrew Mitchell President, Exzeo Group. Tampa, FL | $10.9M |
Other Adaptive Biotechnologies insiders
All ADPT insiders- Chad M. Robins$58.4MCEO and Chairman. #2282 overall
- Harlan S Robins$22.8MChief Scientific Officer. #4699 overall
- Tycho Peterson$14.9MChief Financial Officer. #6474 overall
- Julie Rubinstein$10.6MPresident and COO. #8406 overall
- Kyle Piskel$7.2MChief Financial Officer. #11183 overall
- Francis Lo$6.3MChief People Officer. #12386 overall
Questions
How much stock does Susan Bobulsky own?
Susan Bobulsky holds $10,868,674 in listed stock based on SEC filings and current prices, mostly Adaptive Biotechnologies (ADPT). That ranks 8231st on the Stock Rich List.
Is this Susan Bobulsky's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Susan Bobulsky last buy or sell stock?
The most recent open-market trade on file is a sale of 1,875 ADPT shares on Nov 11, 2026 at $32.00.